Outcomes of concurrent radiotherapy and weekly paclitaxel/carboplatin therapy in cervical cancer: a retrospective study.
CONCLUSIONS: For cervical cancer treatment, CCRT with paclitaxel/car- boplatin is satisfactory.
PMID: 29894076 [PubMed - in process]
Source: European Journal of Gynaecological Oncology - Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | OBGYN | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology